Department of Cardiac Surgery, University of Michigan, Ann Arbor (D.M., H.F., B.Y.).
Xiangya School of Medicine, Central South University, Changsha, China (H.F.).
Arterioscler Thromb Vasc Biol. 2022 Aug;42(8):919-930. doi: 10.1161/ATVBAHA.122.317484. Epub 2022 Jun 16.
Thoracic aortic aneurysm is a life-threatening condition caused by weakening of the thoracic aorta wall, often developing silently until dissection or rupture occurs. Despite substantial efforts in the past decade, there have been no significant therapeutic advances to prevent or clinically manage diverse forms of thoracic aortic aneurysm and dissection with the only effective treatment being surgical repair. There is an urgent need to understand intra- and inter-aneurysmal heterogeneity underlying thoracic aortic aneurysm and dissection pathogenesis. The human aortic wall consists of many cell types and exhibits significant regional heterogeneity. High-throughput single-cell RNA sequencing has emerged as the principal tool to reveal the complexity in human tissues and clinical specimens. Recent single-cell RNA sequencing studies of different aortic cell populations both in vivo and in vitro began to dissect this complexity and have provided valuable information. In this review, we summarize these findings and discuss the potential applications of single-cell transcriptomics and related high-content technologies in human thoracic aortic aneurysm and dissection research, as well as the challenges associated with it.
胸主动脉瘤是一种危及生命的疾病,由胸主动脉壁的弱化引起,通常在夹层或破裂发生之前无声无息地发展。尽管在过去十年中做出了巨大努力,但在预防或临床管理各种形式的胸主动脉瘤和夹层方面仍没有重大的治疗进展,唯一有效的治疗方法是手术修复。迫切需要了解胸主动脉瘤和夹层发病机制中的腔内和腔外异质性。人主动脉壁由许多细胞类型组成,表现出明显的区域异质性。高通量单细胞 RNA 测序已成为揭示人体组织和临床标本复杂性的主要工具。最近对体内和体外不同的主动脉细胞群进行的单细胞 RNA 测序研究开始剖析这种复杂性,并提供了有价值的信息。在这篇综述中,我们总结了这些发现,并讨论了单细胞转录组学及相关高内涵技术在人胸主动脉瘤和夹层研究中的潜在应用,以及与之相关的挑战。